604 related articles for article (PubMed ID: 25498866)
1. Development of therapeutics for treatment of Ebola virus infection.
Li H; Ying T; Yu F; Lu L; Jiang S
Microbes Infect; 2015 Feb; 17(2):109-17. PubMed ID: 25498866
[TBL] [Abstract][Full Text] [Related]
2. Small molecule inhibitors of ebola virus infection.
Picazo E; Giordanetto F
Drug Discov Today; 2015 Feb; 20(2):277-86. PubMed ID: 25532798
[TBL] [Abstract][Full Text] [Related]
3. Basic science and the Ebola virus infection epidemic.
DeVane CL
Pharmacotherapy; 2014 Nov; 34(11):1115-7. PubMed ID: 25382095
[No Abstract] [Full Text] [Related]
4. [Recent Advances in Vaccines and Drugs Against the Ebola Virus].
Zhu X; Yao C; Wei Y; Kou Z; Hu K
Bing Du Xue Bao; 2015 May; 31(3):287-92. PubMed ID: 26470536
[TBL] [Abstract][Full Text] [Related]
5. Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.
Dhama K; Karthik K; Khandia R; Chakraborty S; Munjal A; Latheef SK; Kumar D; Ramakrishnan MA; Malik YS; Singh R; Malik SVS; Singh RK; Chaicumpa W
Front Immunol; 2018; 9():1803. PubMed ID: 30147687
[TBL] [Abstract][Full Text] [Related]
6. Development of Potential Small Molecule Therapeutics for Treatment of Ebola Virus Disease.
Schafer A; Cheng H; Lee C; Du R; Han J; Perez J; Peet N; Manicassamy B; Rong L
Curr Med Chem; 2018; 25(38):5177-5190. PubMed ID: 29032747
[TBL] [Abstract][Full Text] [Related]
7. Treatment of ebola virus disease.
Kilgore PE; Grabenstein JD; Salim AM; Rybak M
Pharmacotherapy; 2015 Jan; 35(1):43-53. PubMed ID: 25630412
[TBL] [Abstract][Full Text] [Related]
8. The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection.
Wu W; Liu S
Curr Top Med Chem; 2017; 17(3):361-370. PubMed ID: 27572081
[TBL] [Abstract][Full Text] [Related]
9. Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing.
Shrivastava-Ranjan P; Flint M; Bergeron É; McElroy AK; Chatterjee P; Albariño CG; Nichol ST; Spiropoulou CF
mBio; 2018 May; 9(3):. PubMed ID: 29717011
[TBL] [Abstract][Full Text] [Related]
10. Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection.
Tshiani Mbaya O; Mukumbayi P; Mulangu S
Front Immunol; 2021; 12():721328. PubMed ID: 34526994
[TBL] [Abstract][Full Text] [Related]
11. Assessing Antiviral Countermeasures Using Mouse Models of Ebolavirus Infection.
Kroeker A; Griffin BD; Qiu X; Kobinger G
Methods Mol Biol; 2017; 1628():273-282. PubMed ID: 28573628
[TBL] [Abstract][Full Text] [Related]
12. A review on the antagonist Ebola: A prophylactic approach.
Khan FN; Qazi S; Tanveer K; Raza K
Biomed Pharmacother; 2017 Dec; 96():1513-1526. PubMed ID: 29208326
[TBL] [Abstract][Full Text] [Related]
13. Development of treatment strategies to combat Ebola and Marburg viruses.
Paragas J; Geisbert TW
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):67-76. PubMed ID: 16441210
[TBL] [Abstract][Full Text] [Related]
14. Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment.
Sakurai Y; Kolokoltsov AA; Chen CC; Tidwell MW; Bauta WE; Klugbauer N; Grimm C; Wahl-Schott C; Biel M; Davey RA
Science; 2015 Feb; 347(6225):995-8. PubMed ID: 25722412
[TBL] [Abstract][Full Text] [Related]
15. Teicoplanin inhibits Ebola pseudovirus infection in cell culture.
Wang Y; Cui R; Li G; Gao Q; Yuan S; Altmeyer R; Zou G
Antiviral Res; 2016 Jan; 125():1-7. PubMed ID: 26585243
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions.
Bausch DG; Sprecher AG; Jeffs B; Boumandouki P
Antiviral Res; 2008 Apr; 78(1):150-61. PubMed ID: 18336927
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection
Kummer S; Lander A; Goretzko J; Kirchoff N; Rescher U; Schloer S
Emerg Microbes Infect; 2022 Dec; 11(1):195-207. PubMed ID: 34919035
[TBL] [Abstract][Full Text] [Related]
18. [Ebola vaccine and treatment].
Takada A
Uirusu; 2015; 65(1):61-70. PubMed ID: 26923959
[TBL] [Abstract][Full Text] [Related]
19. Ebola Virus Entry: From Molecular Characterization to Drug Discovery.
Salata C; Calistri A; Alvisi G; Celestino M; Parolin C; Palù G
Viruses; 2019 Mar; 11(3):. PubMed ID: 30893774
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Therapeutic Approaches Against Ebola Virus Infection.
Soni M; Tulsian K; Barot P; Vyas VK
Recent Adv Antiinfect Drug Discov; 2024; 19(4):276-299. PubMed ID: 38279760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
